Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DOMINGO, J. L.
Right arrow Articles by PIERA, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DOMINGO, J. L.
Right arrow Articles by PIERA, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

meso-2, 3-Dimercaptosuccinic Acid and Prevention of Arsenite Embryotoxicity and Teratogenicity in the Mouse

J. L. DOMINGO*, M. A. BOSQUE* and V. PIERA{dagger}

*Laboratory of Toxicology and Biochemistry San Lorenzo 21, 43201-Reus, Spain {dagger}Anatomy Unit, School of Medicine, University of Barcelona San Lorenzo 21, 43201-Reus, Spain

Received October 22, 1990; accepted February 18, 1991

meso-2,3-Dimercaptosuccinic Acid and Prevention of Arsenite Embryotoxicity and Teratogenicity in the Mouse. DOMINGO, J. L., BOSQUE, M. A., AND PIERA, V. (1991). Fundom. Appl. To. 17, 314–320. meso2,3-Dimercaptosuccinic acid (DMSA), an antidote for the treatment of experimental and human poisoning by a number of heavy metals, has been reported to reduce the lethality of animals poisoned with arsenic more effectively than 2,3-dimercaptopropanol. In the present study, the effcct of DMSA on arsenite-induced embryotoxic and teratogenic effects was evaluated in mice. In a first experiment, a series of four DMSA injections was administered sc to pregnant Swiss mice immediately after a single i p injection of 12 mg/kg of sodium aresenite (NaAsO2) given on Day 10 of gestation, and at 24, 48, and 72 hr thereafter. DMSA effectiveness was assessed at dosage levels of 0, 80, 160, and 320 mg/kg/day. Treatment with DMSA significantly reduced the embryolethality and the incidence of gross external and skeletal malformations and variations provoked by NaAsO2. Based on these findings, the effect of increasing the time interval between acute arsenite exposure and mitiation of DMSA therapy was invmgated in a second experiment. On Day 10 of gestation, DMSA (320 mg/kg) was administered sc to pregnant mice at 0, 0.25, 0.50, 1, 4, or 12 hr after a 12-mg/kg ip dose of NaAsO2. Embryotoxicity and teratogenicity derived from NaAsO2 exposure were significantly reduced when DMSA was given during the first hour aRer NaAsO2 injection. According to these results, a delay between acute arsenite intoxication and DMSA treatment should be avoided to have a practical beneficial effect on the arsenite exposed conceptus.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.